We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tristel Plc | LSE:TSTL | London | Ordinary Share | GB00B07RVT99 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 462.50 | 455.00 | 470.00 | 462.50 | 462.50 | 462.50 | 37,018 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 36.01M | 4.46M | 0.0941 | 49.15 | 219.23M |
TIDMTSTL
Tristel PLC
27 February 2017
Tristel plc
("Tristel" or the "Company")
Tristel's Wipes and foam disinfectants included in Journal of Ultrasound in Medicine & Biology
Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that the World Federation for Ultrasound in Medicine & Biology has provided guidance to healthcare organisations worldwide regarding the safe and effective cleaning and disinfection of transvaginal and transrectal ultrasound probes.
The Technical Note identifies various high-level disinfectants that are recommended by ultrasound manufacturers and comments that Tristel's chlorine dioxide is being used extensively in the United Kingdom and Australia. Both the Trio Wipes System and the Duo Foam product are named. Tristel is pursuing a regulatory approval from the United States Food and Drug Administration (FDA) for the Duo Foam.
The Technical Note concludes that disinfection of the ultrasound probe is mandatory. However, in many countries probes are not disinfected even though the probe is used in gynaecological procedures where there is a proven high risk of contamination of the instrument by pathogens such as human immunodeficiency virus (HIV) and human papillomavirus (HPV). HPV is proven to be the main causal agent for cervical cancer. In addition, specific concerns include gonorrhoea and syphilis for vaginal probes and Clostridium difficile for transrectal probes.
The study has been published as a Technical Note in the Journal of Ultrasound in Medicine & Biology
[Abramovich, J. S., Evans, D. H., Fowlkes, J. B., Marsal, K., terHaar, G. 'Guidelines for Cleaning Transvaginal Ultrasound Transducers Between Patients', (2017). DOI: 10.1016/j.ultrasmedbio.2017.01.002].
Paul Swinney, CEO of Tristel plc, comments: "Ultrasound scans in women's health are one of the world's most commonplace diagnostic procedures. It is astounding that so many of these procedures are undertaken without the instrument being properly disinfected between patients. Our Trio and Duo products are two of very few disinfectant products that are designed specifically for women's health. Guidance such as this from the World Federation can only encourage patients to demand that the instrument being used on them is safe because it has been properly disinfected."
For further information please contact:
Tristel plc www.tristel.com Paul Swinney, Chief Executive Tel: 01638 721 500 Liz Dixon, Finance Director finnCap Geoff Nash / Giles Rolls, Tel: 020 7220 0500 Corporate Finance Alice Lane, Corporate Broking Walbrook PR Ltd Tel: 020 7933 8780 or tristel@walbrookpr.com Paul McManus Mob: 07980 541 893 Lianne Cawthorne Mob: 07584 391 303
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRALLFLDFVISFID
(END) Dow Jones Newswires
February 27, 2017 02:01 ET (07:01 GMT)
1 Year Tristel Chart |
1 Month Tristel Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions